251 related articles for article (PubMed ID: 25461359)
1. Morphological and immunohistochemical pattern of tubo-ovarian dysplasia and serous tubal intraepithelial carcinoma.
Chene G; Cayre A; Raoelfils I; Lagarde N; Dauplat J; Penault-Llorca F
Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():89-95. PubMed ID: 25461359
[TBL] [Abstract][Full Text] [Related]
2. Morphological and immunohistochemical study of ovarian and tubal dysplasia associated with tamoxifen.
Chene G; Radosevic-Robin N; Tardieu AS; Cayre A; Raoelfils I; Dechelotte P; Dauplat J; Penault Llorca F
Eur J Histochem; 2014 Apr; 58(2):2251. PubMed ID: 24998918
[TBL] [Abstract][Full Text] [Related]
3. Early detection of high-grade tubal serous carcinoma in women at low risk for hereditary breast and ovarian cancer syndrome by systematic examination of fallopian tubes incidentally removed during benign surgery.
Rabban JT; Garg K; Crawford B; Chen LM; Zaloudek CJ
Am J Surg Pathol; 2014 Jun; 38(6):729-42. PubMed ID: 24820399
[TBL] [Abstract][Full Text] [Related]
4. Fallopian tube intraluminal tumor spread from noninvasive precursor lesions: a novel metastatic route in early pelvic carcinogenesis.
Bijron JG; Seldenrijk CA; Zweemer RP; Lange JG; Verheijen RH; van Diest PJ
Am J Surg Pathol; 2013 Aug; 37(8):1123-30. PubMed ID: 23648462
[TBL] [Abstract][Full Text] [Related]
5. Early telomere shortening and genomic instability in tubo-ovarian preneoplastic lesions.
Chene G; Tchirkov A; Pierre-Eymard E; Dauplat J; Raoelfils I; Cayre A; Watkin E; Vago P; Penault-Llorca F
Clin Cancer Res; 2013 Jun; 19(11):2873-82. PubMed ID: 23589176
[TBL] [Abstract][Full Text] [Related]
6. [Morphologic changes of fallopian tubal epithelium in ovarian serous tumors].
Wen J; Shi JL; Shen DH; Chen YX; Song QJ
Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):433-7. PubMed ID: 22932451
[TBL] [Abstract][Full Text] [Related]
7. Incidental serous tubal intraepithelial carcinoma and early invasive serous carcinoma in the nonprophylactic setting: analysis of a case series.
Morrison JC; Blanco LZ; Vang R; Ronnett BM
Am J Surg Pathol; 2015 Apr; 39(4):442-53. PubMed ID: 25517955
[TBL] [Abstract][Full Text] [Related]
8. p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary.
Leonhardt K; Einenkel J; Sohr S; Engeland K; Horn LC
Int J Gynecol Pathol; 2011 Sep; 30(5):417-24. PubMed ID: 21804388
[TBL] [Abstract][Full Text] [Related]
9. Are all pelvic (nonuterine) serous carcinomas of tubal origin?
Przybycin CG; Kurman RJ; Ronnett BM; Shih IeM; Vang R
Am J Surg Pathol; 2010 Oct; 34(10):1407-16. PubMed ID: 20861711
[TBL] [Abstract][Full Text] [Related]
10. Fallopian Tube Lesions in Women at High Risk for Ovarian Cancer: A Multicenter Study.
Visvanathan K; Shaw P; May BJ; Bahadirli-Talbott A; Kaushiva A; Risch H; Narod S; Wang TL; Parkash V; Vang R; Levine DA; Soslow R; Kurman R; Shih IM
Cancer Prev Res (Phila); 2018 Nov; 11(11):697-706. PubMed ID: 30232083
[TBL] [Abstract][Full Text] [Related]
11. [Morphologic features of fallopian tubal epithelium in pelvic high-grade serous carcinoma].
Zhao RJ; Wang YY; Li Z; Wu KY; Kong LF; Zheng WX
Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):542-547. PubMed ID: 28810294
[No Abstract] [Full Text] [Related]
12. A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development.
Sherman-Baust CA; Kuhn E; Valle BL; Shih IeM; Kurman RJ; Wang TL; Amano T; Ko MS; Miyoshi I; Araki Y; Lehrmann E; Zhang Y; Becker KG; Morin PJ
J Pathol; 2014 Jul; 233(3):228-37. PubMed ID: 24652535
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Primary Cilia in Normal Fallopian Tube Epithelium and Serous Tubal Intraepithelial Carcinoma.
Abdelhamed ZA; Ryan TA; Fuller M; Coulson-Gilmer C; Abdelmottaleb DI; Wang TL; Kaun JC; Wang P; Hutson R; Wilkinson N; Bell SM; Johnson CA
Int J Gynecol Cancer; 2018 Oct; 28(8):1535-1544. PubMed ID: 30095490
[TBL] [Abstract][Full Text] [Related]
14. Serous tubal intraepithelial carcinoma localizes to the tubal-peritoneal junction: a pivotal clue to the site of origin of extrauterine high-grade serous carcinoma (ovarian cancer).
Seidman JD
Int J Gynecol Pathol; 2015 Mar; 34(2):112-20. PubMed ID: 25675178
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of p-ERM, a marker of cell polarity, in benign and neoplastic oviductal epithelium.
Ning G; Bijron JG; Yuan J; Hirsch MS; McKeon FD; Nucci MR; Crum CP; Xian W
Int J Gynecol Pathol; 2013 Jul; 32(4):345-52. PubMed ID: 23722506
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic and biological implications of laminin expression in serous tubal intraepithelial carcinoma.
Kuhn E; Kurman RJ; Soslow RA; Han G; Sehdev AS; Morin PJ; Wang TL; Shih IeM
Am J Surg Pathol; 2012 Dec; 36(12):1826-34. PubMed ID: 22892598
[TBL] [Abstract][Full Text] [Related]
17. Secretory cell outgrowths, p53 signatures, and serous tubal intraepithelial carcinoma in the fallopian tubes of patients with sporadic pelvic serous carcinoma.
Mittal N; Srinivasan R; Gupta N; Rajwanshi A; Nijhawan R; Gautam U; Sood S; Dhaliwal L
Indian J Pathol Microbiol; 2016; 59(4):481-488. PubMed ID: 27721278
[TBL] [Abstract][Full Text] [Related]
18. [Expansion of secretory cells in the fallopian tubal epithelium in the early stages of the pathogenesis of ovarian serous carcinomas].
Asaturova AV; Ezhova LS; Faizullina NM; Adamyan LV; Khabas GN; Sannikova MV
Arkh Patol; 2017; 79(3):10-18. PubMed ID: 28631711
[TBL] [Abstract][Full Text] [Related]
19. LEF1 is preferentially expressed in the tubal-peritoneal junctions and is a reliable marker of tubal intraepithelial lesions.
Schmoeckel E; Odai-Afotey AA; Schleißheimer M; Rottmann M; Flesken-Nikitin A; Ellenson LH; Kirchner T; Mayr D; Nikitin AY
Mod Pathol; 2017 Sep; 30(9):1241-1250. PubMed ID: 28664938
[TBL] [Abstract][Full Text] [Related]
20. Serous tubal intraepithelial carcinoma, chronic fallopian tube injury, and serous carcinoma development.
Malmberg K; Klynning C; Flöter-Rådestad A; Carlson JW
Virchows Arch; 2016 Jun; 468(6):707-13. PubMed ID: 27003156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]